Waltham Woods
Update
12/07/21
166K SF Lease Signed at 890 Winter Street in Waltham
Boston Properties, Inc has announced three leases totaling 166,000 square feet at its life sciences conversion project at 880 Winter Street in Waltham, Massachusetts. With these leases, the 244,000 square foot project, which is expected to deliver in the second half of 2022 is approximately 70% pre-leased.
“We are thrilled by these agreements, as they reinforce the desirability of Waltham as a leading destination for life sciences organizations to attract and retain key talent and facilitate scientific discoveries,” stated Bryan Koop, Executive Vice President, Boston Region, BXP. “In addition, they demonstrate our continued ability to convert existing buildings for life science uses to meet the growing demand for space by organizations in the industry.”
The 166,000 square feet of leasing includes:
A 115,000 square foot lease with TScan Therapeutics, Inc., a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer.
A 37,000 square foot lease with RVAC Medicines, an mRNA biotechnology company building a pipeline of innovative mRNA vaccine and therapeutic candidates to treat various diseases of unmet medical needs.
A 14,000 square foot lease with EdiGene, a global clinical-stage biotechnology company focused on leveraging cutting-edge genome editing technologies to accelerate drug discovery and the development of novel therapeutics for a broad range of genetic diseases and cancer.
“BXP Life Sciences is focused on creating space and place for scientific discovery,” stated David Provost, Senior Vice President of Development and Co-Head of BXP Life Sciences. “We are proud that these three cutting-edge biotechnology companies have selected 880 Winter Street as the ideal location to serve their missions.”
880 Winter Street, located adjacent to the Company’s Bay Colony properties in Waltham, is a 244,000 square foot property currently being redeveloped by BXP and converted into lab space. The redevelopment of 880 Winter Street builds on BXP’s 4.9 million square feet of lab and Class A office properties in the Waltham/Lexington region of Massachusetts, which continues to be a destination of choice for leading life sciences organizations.
